Navient Corp/ US63938C1080 /
13/06/2024 21:59:49 | Var. +0.10 | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
14.58USD | +0.69% | 21,228 Fatturato: 309,375.36 |
-Quantità in denaro: - | -Quantità in lettera: - | 1.63 bill.USD | 4.39% | 7.79 |
GlobeNewswire
09:11
Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire
09:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
09:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
09:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
09:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
08:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
07:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...